Shimoda K - Search Results

1

Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F.

Shide K, Shimoda HK, Kumano T, Karube K, Kameda T, Takenaka K, Oku S, Abe H, Katayose KS, Kubuki Y, Kusumoto K, Hasuike S, Tahara Y, Nagata K, Matsuda T, Ohshima K, Harada M, Shimoda K. Shide K, et al. Among authors: shimoda hk, shimoda k. Leukemia. 2008 Jan;22(1):87-95. doi: 10.1038/sj.leu.2405043. Epub 2007 Nov 22. Leukemia. 2008. PMID: 18033315

2

Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions.

Omori F, Okamura S, Shimoda K, Otsuka T, Harada M, Niho Y. Omori F, et al. Among authors: shimoda k. Biotherapy. 1992;4(2):147-53. doi: 10.1007/BF02171759. Biotherapy. 1992. PMID: 1377927

3

The c-kit molecule and the surface immunophenotype of human acute leukemia.

Kubota A, Okamura S, Shimoda K, Harada M, Niho Y. Kubota A, et al. Among authors: shimoda k. Leuk Lymphoma. 1994 Aug;14(5-6):421-8. doi: 10.3109/10428199409049699. Leuk Lymphoma. 1994. PMID: 7529077

4

Analysis of c-kit expression of human erythroleukemia cell line, HEL: clonal variation and relationship with erythroid and megakaryocytic phenotype.

Kubota A, Okamura S, Shimoda K, Ikematsu W, Otsuka T, Niho Y. Kubota A, et al. Among authors: shimoda k. Leuk Res. 1995 Apr;19(4):283-90. doi: 10.1016/0145-2126(94)00160-c. Leuk Res. 1995. PMID: 7538619

5

Myasthenia gravis after allogeneic bone marrow transplantation.

Shimoda K, Gondo H, Harada M, Sano T, Nakamura M, Otsuka T, Okamura S, Niho Y. Shimoda K, et al. Bone Marrow Transplant. 1994 Jul;14(1):155-6. Bone Marrow Transplant. 1994. PMID: 7951105

6

Production of soluble granulocyte colony-stimulating factor receptors from myelomonocytic cells.

Iwasaki H, Shimoda K, Okamura S, Otsuka T, Nagafuji K, Harada N, Ohno Y, Miyamoto T, Akashi K, Harada M, Niho Y. Iwasaki H, et al. Among authors: shimoda k. J Immunol. 1999 Dec 15;163(12):6907-11. J Immunol. 1999. PMID: 10586093

7

Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony-stimulating factor.

Akashi K, Eto T, Shibuya T, Shimoda K, Harada M, Niho Y. Akashi K, et al. Among authors: shimoda k. Leuk Res. 2000 Mar;24(3):243-8. doi: 10.1016/s0145-2126(99)00175-7. Leuk Res. 2000. PMID: 10739006

8

Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.

Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, Yamashita M, Numata A, Takase K, Kobayashi S, Shibata S, Asano Y, Gondo H, Sekiguchi K, Nakayama K, Nakayama T, Okamura T, Okamura S, Niho Y, Nakayama K. Shimoda K, et al. Immunity. 2000 Oct;13(4):561-71. doi: 10.1016/s1074-7613(00)00055-8. Immunity. 2000. PMID: 11070174 Free article.

9

Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice.

Shimoda K, Tsutsui H, Aoki K, Kato K, Matsuda T, Numata A, Takase K, Yamamoto T, Nukina H, Hoshino T, Asano Y, Gondo H, Okamura T, Okamura S, Nakayama K, Nakanishi K, Niho Y, Harada M. Shimoda K, et al. Blood. 2002 Mar 15;99(6):2094-9. doi: 10.1182/blood.v99.6.2094. Blood. 2002. PMID: 11877284 Free article.

10

Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation.

Shimoda K, Kamesaki K, Numata A, Aoki K, Matsuda T, Oritani K, Tamiya S, Kato K, Takase K, Imamura R, Yamamoto T, Miyamoto T, Nagafuji K, Gondo H, Nagafuchi S, Nakayama K, Harada M. Shimoda K, et al. J Immunol. 2002 Nov 1;169(9):4707-11. doi: 10.4049/jimmunol.169.9.4707. J Immunol. 2002. PMID: 12391177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

891 results

Search Page

Filters